Cancer Network interview of pharmacy ... - Advanced Prostate...
Cancer Network interview of pharmacy expert re shortages of carboplatin and cisplatin; mitigation strategies
Written by
garyjp9
To view profiles and participate in discussions please or .
Read more about...
2 Replies
•
I don’t intend this as a political post. I do not understand why we do not manufacture critical drugs in the United States rather than be dependent on supplies from other countries. I hate to be naive and realize production costs are less in the two countries mentioned here ( India and China). Is it patents or economics?
Both. Once a patent expires, a drug can be made generically, which can lead to a lot of cost cutting and quality control issues. nytimes.com/2023/05/17/heal...
Not what you're looking for?
You may also like...
My 22 month psa after radiation treatment (SBRT) is 1.25. What should my nadir be? Less than 0.5?
9/24/14 (4.69) 10/18/13 (3.79) 3/22/12 (3.97),
https://mail.google.com/mail/u/0/?tab=cm#inbox/KtbxLw
Information on nmCRPC disease state?
-in-prostate-cancer?eKey=bW9lc3B5QGNvbWNhc3QubmV0&utm_medium=email&utm_campaign=ONCSS%20Prostate%20C